MARCHIANO', SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 1.228
EU - Europa 586
AS - Asia 494
AF - Africa 2
SA - Sud America 1
Totale 2.311
Nazione #
US - Stati Uniti d'America 1.222
IE - Irlanda 209
SG - Singapore 176
IT - Italia 172
VN - Vietnam 117
HK - Hong Kong 90
CN - Cina 80
RU - Federazione Russa 34
FR - Francia 30
DE - Germania 27
FI - Finlandia 18
SE - Svezia 17
NL - Olanda 15
UA - Ucraina 15
BE - Belgio 12
GB - Regno Unito 10
AT - Austria 9
KR - Corea 9
LB - Libano 6
TR - Turchia 6
CA - Canada 5
CH - Svizzera 4
UZ - Uzbekistan 4
CZ - Repubblica Ceca 3
TW - Taiwan 3
AL - Albania 2
GR - Grecia 2
PL - Polonia 2
AZ - Azerbaigian 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CL - Cile 1
IR - Iran 1
JP - Giappone 1
LT - Lituania 1
MA - Marocco 1
MX - Messico 1
NO - Norvegia 1
PT - Portogallo 1
RO - Romania 1
Totale 2.311
Città #
Chandler 322
Dublin 205
Singapore 141
San Mateo 119
Dong Ket 117
Hong Kong 90
Perugia 69
Ann Arbor 63
Santa Clara 57
Boardman 51
Medford 51
Princeton 50
Altamura 40
Lawrence 40
Wilmington 34
Beijing 31
Andover 30
Redmond 17
Saint Petersburg 14
Brussels 12
Dallas 12
Houston 12
Redwood City 11
Den Haag 10
Des Moines 9
Los Angeles 9
Seoul 9
Helsinki 8
Ashburn 7
Norwalk 7
Chicago 6
Izmir 6
San Paolo di Civitate 6
Vienna 6
Dearborn 5
Falls Church 5
Munich 5
Cambridge 4
Jacksonville 4
Woodbridge 4
Florence 3
Frankfurt am Main 3
Toronto 3
Chiyayi County 2
Guangzhou 2
Lappeenranta 2
Lausanne 2
London 2
Menlo Park 2
Nanning 2
Naples 2
Olomouc 2
Ottawa 2
Rome 2
San Diego 2
Stenico 2
Stroncone 2
Abidjan 1
Alba 1
Anguillara Sabazia 1
Athens 1
Avignon 1
Baku 1
Baotou 1
Bastia umbra 1
Bologna 1
Brno 1
Caserta 1
Castiglione del Lago 1
Cava Dei Tirreni 1
Cormeilles-en-Parisis 1
Esslingen am Neckar 1
Fremont 1
Handan 1
Hangzhou 1
Harbin 1
Hefei 1
Iglesias 1
Jinan 1
Lexington 1
Magdeburg 1
Marseille 1
Milan 1
Moscow 1
Nanchang 1
Nanjing 1
Napoli 1
New York 1
Phoenix 1
Rabat 1
Radeberg 1
Seattle 1
Shanghai 1
Shenyang 1
Taipei 1
Tenhult 1
Timisoara 1
Tiranë 1
Tokyo 1
Turin 1
Totale 1.778
Nome #
BAR502, a Dual FXR and GPBAR1 Agonist, Reverses Steatosis and Fibrosis in Rodent Model of NASH By Modulating Authophagic Genes 88
The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines 85
The bile acid receptor GPBAR1 regulates the M1/M2 phenotype of intestinal macrophages and activation of gpbar1 rescues mice from murine colitis 85
The aryl hydrocarbon receptor (AhR) mediates the counter-regulatory effects of pelargonidins in models of inflammation and metabolic dysfunctions 77
BAR501, A SELECTIVE GPBAR1 AGONIST, PROMOTES ADIPOSE TISSUE BROWNING AND AUTOPHAGY AND IMPROVES LIPID METABOLISM AND STEATO-HEPATITIS IN MICE FEED A HIGH FAT DIET 71
A Comprehensive Analysis of Small Heterodimer Partner (SHP) Target Genes in Hepatic Stellate Cells and the Discovery of a New Class of SHP Agonists That Reduces Liver Fibrosis 67
Identification of Cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1 66
Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis 64
BAR130, A HYODEOXYCHOLIC ACID DERIVATIVE AS THE FIRST EXAMPLE OF DUAL LXR alpha/GPBAR1 AGONIST 62
Analysis of Gastric Cancer Transcriptome Allows the Identification of Histotype Specific Molecular Signatures With Prognostic Potential 62
Sa1518 – Mechanism of Acute Liver Decompensation Caused by Obeticholic Acid in Cholestasis is Fxr Dependent 58
241 - GPBAR1 (TGR5) is a Modulator of Liver Immunity and Reverses Liver Inflammation in a Mouse Models of Acute Hepatitis 57
Su1053 - Bar704, a Potent and Selective Fxr Agonist Protects Against Intestinal Fibrosis 55
BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis 54
Genetic and Pharmacological Dissection of the Role of Spleen Tyrosine Kinase (Syk) in Intestinal Inflammation and Immune Dysfunction in Inflammatory Bowel Diseases 53
Mo2014 – Comparative Effects of Bar502, a Dual Fxr and Gpbar1 Agonist, Obeticholic Acid and Ursodeoxycholic Acid in a Rodent Model of Nash 53
Tu1546 – Gpbar1 is a Modulator of Liver Immunity and Its Agonism Reverses Acetaminophen-Induced Hepatotoxicity by Modulating Recruitment of Liver Macrophages 53
Metabolic variability of a multispecies probiotic preparation impacts on the anti-inflammatory activity 50
Tu1738 - The Aryl Hydrocarbon Receptor Mediates Anti-Inflammatory Activities of Natural and Synthetic Pelargonidines in Mouse Models of Colitis 49
Disruption of TFG beta-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand 49
Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH 48
The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver Toxicity 48
Divergent effectiveness of multispecies probiotic preparations on intestinal microbiota structure depends on metabolic properties 47
GPBAR1 Activation by C6-Substituted Hyodeoxycholane Analogues Protect against Colitis 47
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 46
Bile Acids Activated Receptors in Inflammatory Bowel Disease 46
Investigation around the Oxadiazole Core in the Discovery of a New Chemotype of Potent and Selective FXR Antagonists 45
Nanotraps with biomimetic surface as decoys for chemokines 44
Discovery of a Novel Multi-Strains Probiotic Formulation with Improved Efficacy toward Intestinal Inflammation 44
Gpbar1 agonism promotes a Pgc-1α-dependent browning of white adipose tissue and energy expenditure and reverses diet-induced steatohepatitis in mice 43
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis 43
Discovery of ((1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl)ureidyl derivatives as selective non-steroidal agonists of the G-protein coupled bile acid receptor-1 41
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling 40
GPBAR1 (TGR5) LIGATION PROTECTS AGAINST COLITIS DEVELOPMENT BY REGULATING LEUKOCYTE TRAFFINKING AND PROMOTING A IL-10 DEPENDENT SHIFT IN THE M1/M2 PHENOTYPE 39
Tu1748 - Probiotics Beyond Taxonomy: Evidence that Anti-inflammatory Properties of Live Biotherapeutic Products Require Phenotypic Characterization 39
Transcriptome Analysis of Dual FXR and GPBAR1 Agonism in Rodent Model of NASH Reveals Modulation of Lipid Droplets Formation 39
GLP-1 Mediates Regulation of Colonic ACE2 Expression by the Bile Acid Receptor GPBAR1 in Inflammation 39
GPBAR1 (TGR5) AGONISM REVERSES ENDOTHELIAL DYSFUNCTION AND LIVER INJURY IN A DIETETIC MODEL OF STEATOHEPATITIS 37
Novel Isoxazole Derivatives with Potent FXR Agonistic Activity Prevent Acetaminophen-Induced Liver Injury 37
Discovery of a Potent and Orally Active Dual GPBAR1/CysLT1R Modulator for the Treatment of Metabolic Fatty Liver Disease 37
Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis 37
VARIABILITY IN INDUSTRIAL PRODUCTION AFFECTS PROBIOTICS ACTIVITY: IDENTIFICATION OF BATCHES OF PROBIOTIC VSL#3 THAT INCREASES INTESTINAL PERMEABILITY AND WORSENS COLITIS IN RODENTS 36
GPBAR1 Functions as Gatekeeper for Liver NKT Cells and provides Counterregulatory Signals in Mouse Models of Immune-Mediated Hepatitis 36
Epoxide functionalization on cholane side chains in the identification of G-protein coupled bile acid receptor (GPBAR1) selective agonists 34
The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy 34
Introduction of Nonacidic Side Chains on 6-Ethylcholane Scaffolds in the Identification of Potent Bile Acid Receptor Agonists with Improved Pharmacokinetic Properties 32
Endocrine activities and adipogenic effects of bisphenol AF and its main metabolite 30
Targeting Bile Acid Receptors: Discovery of a Potent and Selective Farnesoid X Receptor Agonist as a New Lead in the Pharmacological Approach to Liver Diseases 26
Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain 25
Organoids as ex vivo culture system to investigate infection-host interaction in gastric pre-carcinogenesis 25
Hyodeoxycholic acid derivatives as liver X receptor α and G-protein-coupled bile acid receptor agonists 23
Totale 2.445
Categoria #
all - tutte 13.174
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.174


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020105 0 0 0 0 0 7 27 8 8 38 13 4
2020/2021301 9 9 3 10 87 18 11 3 7 10 8 126
2021/2022443 7 92 2 14 11 4 20 113 9 43 57 71
2022/2023862 62 174 8 69 86 83 0 46 286 2 34 12
2023/2024291 18 31 8 6 5 3 79 18 3 14 66 40
2024/2025294 10 63 43 36 74 68 0 0 0 0 0 0
Totale 2.445